1264 related articles for article (PubMed ID: 28642841)
21. Immunostimulatory efficacy and protective potential of putative TgERK7 protein in mice experimentally infected by Toxoplasma gondii.
Li ZY; Guo HT; Calderón-Mantilla G; He JJ; Wang JL; Bonev BB; Zhu XQ; Elsheikha HM
Int J Med Microbiol; 2020 Jul; 310(5):151432. PubMed ID: 32654774
[TBL] [Abstract][Full Text] [Related]
22. Protective immunity induced by a DNA vaccine expressing eIF4A of Toxoplasma gondii against acute toxoplasmosis in mice.
Chen J; Huang SY; Li ZY; Yuan ZG; Zhou DH; Petersen E; Zhang NZ; Zhu XQ
Vaccine; 2013 Mar; 31(13):1734-9. PubMed ID: 23370151
[TBL] [Abstract][Full Text] [Related]
23. Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine.
Gazzinelli RT; Hakim FT; Hieny S; Shearer GM; Sher A
J Immunol; 1991 Jan; 146(1):286-92. PubMed ID: 1670604
[TBL] [Abstract][Full Text] [Related]
24. GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii.
Jongert E; de Craeye S; Dewit J; Huygen K
Parasite Immunol; 2007 Sep; 29(9):445-53. PubMed ID: 17727568
[TBL] [Abstract][Full Text] [Related]
25. Resistance to Chronic
Hu LY; Zhang NZ; Zhang FK; Wang M; Gao Q; Wang JL; Zhu XQ
Biomed Res Int; 2017; 2017():1295038. PubMed ID: 28875149
[No Abstract] [Full Text] [Related]
26. IL-15 prolongs the duration of CD8+ T cell-mediated immunity in mice infected with a vaccine strain of Toxoplasma gondii.
Khan IA; Casciotti L
J Immunol; 1999 Oct; 163(8):4503-9. PubMed ID: 10510393
[TBL] [Abstract][Full Text] [Related]
27. SAG1 is a host-targeted antigen for protection against toxoplasma gondii infection.
Seng S; Makala LH; Yokoyama M; Lim C; Choi YH; Suzuki N; Toyoda Y; Nagasawa H
Pathobiology; 2004; 71(3):144-51. PubMed ID: 15051927
[TBL] [Abstract][Full Text] [Related]
28. An enhanced GRA1-GRA7 cocktail DNA vaccine primes anti-Toxoplasma immune responses in pigs.
Jongert E; Melkebeek V; De Craeye S; Dewit J; Verhelst D; Cox E
Vaccine; 2008 Feb; 26(8):1025-31. PubMed ID: 18221825
[TBL] [Abstract][Full Text] [Related]
29. IL-15 augments CD8+ T cell-mediated immunity against Toxoplasma gondii infection in mice.
Khan IA; Kasper LH
J Immunol; 1996 Sep; 157(5):2103-8. PubMed ID: 8757333
[TBL] [Abstract][Full Text] [Related]
30. Humoral responses and immune protection in mice immunized with irradiated T. gondii tachyzoites and challenged with three genetically distinct strains of T. gondii.
Zorgi NE; Costa A; Galisteo AJ; do Nascimento N; de Andrade HF
Immunol Lett; 2011 Aug; 138(2):187-96. PubMed ID: 21545808
[TBL] [Abstract][Full Text] [Related]
31. Peroxiredoxin 3 promotes IL-12 production from macrophages and partially protects mice against infection with Toxoplasma gondii.
Fereig RM; Nishikawa Y
Parasitol Int; 2016 Dec; 65(6 Pt A):741-748. PubMed ID: 27644889
[TBL] [Abstract][Full Text] [Related]
32. A Lactate Fermentation Mutant of
Xia N; Zhou T; Liang X; Ye S; Zhao P; Yang J; Zhou Y; Zhao J; Shen B
Front Immunol; 2018; 9():1814. PubMed ID: 30147689
[No Abstract] [Full Text] [Related]
33. Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice.
Qu D; Wang S; Cai W; Du A
Vaccine; 2008 Aug; 26(35):4541-8. PubMed ID: 18590785
[TBL] [Abstract][Full Text] [Related]
34. Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of toxoplasma gondii induces immune response and protection against infection in mice.
Caetano BC; Bruña-Romero O; Fux B; Mendes EA; Penido ML; Gazzinelli RT
Hum Gene Ther; 2006 Apr; 17(4):415-26. PubMed ID: 16610929
[TBL] [Abstract][Full Text] [Related]
35. Toxoplasma gondii protease inhibitor-1 (TgPI-1) is a novel vaccine candidate against toxoplasmosis.
Cuppari AF; Sanchez V; Ledesma B; Frank FM; Goldman A; Angel SO; Martin V
Vaccine; 2008 Sep; 26(39):5040-5. PubMed ID: 18675873
[TBL] [Abstract][Full Text] [Related]
36. Mucosal and systemic cellular immune responses induced by Toxoplasma gondii antigens in cyst orally infected mice.
Chardès T; Velge-Roussel F; Mevelec P; Mevelec MN; Buzoni-Gatel D; Bout D
Immunology; 1993 Mar; 78(3):421-9. PubMed ID: 8478024
[TBL] [Abstract][Full Text] [Related]
37. PD-L1, TIM-3, and CTLA-4 Blockade Fails To Promote Resistance to Secondary Infection with Virulent Strains of Toxoplasma gondii.
Splitt SD; Souza SP; Valentine KM; Castellanos BE; Curd AB; Hoyer KK; Jensen KDC
Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29967089
[TBL] [Abstract][Full Text] [Related]
38. Construction and immunogenicity of pseudotype baculovirus expressing Toxoplasma gondii SAG1 protein in BALB/c mice model.
Fang R; Feng H; Nie H; Wang L; Tu P; Song Q; Zhou Y; Zhao J
Vaccine; 2010 Feb; 28(7):1803-7. PubMed ID: 20018269
[TBL] [Abstract][Full Text] [Related]
39. Prime-boost vaccination with toxoplasma lysate antigen, but not with a mixture of recombinant protein antigens, leads to reduction of brain cyst formation in BALB/c mice.
Wagner A; Schabussova I; Ruttkowski B; Peschke R; Kur J; Kundi M; Joachim A; Wiedermann U
PLoS One; 2015; 10(5):e0126334. PubMed ID: 26010355
[TBL] [Abstract][Full Text] [Related]
40. Cell mediated and innate immune responses in pigs following vaccination and challenge with Toxoplasma parasites.
Bartley PM; Burrells A; Benavides J; Canton G; Garcia JL; Thomson J; Chianini F; Innes EA; Katzer F
Vet Parasitol; 2019 Nov; 275():108963. PubMed ID: 31669836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
